Baloxavir Marboxil
2 NDCs across 1 manufacturer|0 Generic,2 Brand
▸ More about this market▾ Less
The brand product was first FDA-approved on Oct 24, 2018, and the first generic was approved Jun 17, 2026. FDA's Orange Book lists 4 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $1 million on Baloxavir Marboxil across 7,723 claims for 7,548 beneficiaries.
Baloxavir Marboxil is available as 2 NDCs from 1 manufacturer (0 generic, 2 brand), with NADAC prices from $161.94 to $161.95 per EA — a 0% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
2
0G / 2B
Manufacturers
1
competing in market
Price Spread
$161.94 – $161.95
per EA
7d Activity
avg +0.0% WoW · of 2 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Genentech, Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
1 manufacturer producing BALOXAVIR MARBOXIL
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
XOFLUZA 80 MG TABLET | $161.9469 per EA | — |
XOFLUZA 40 MG TABLET | $161.9388 per EA | — |
Frequently Asked Questions
When did Baloxavir Marboxil become available as a generic?
FDA approved the first generic Baloxavir Marboxil (ANDA) on Jun 17, 2026. The Orange Book currently lists 4 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Baloxavir Marboxil?
In 2024, Medicare Part D spent $1 million on Baloxavir Marboxil across 7,723 claims for 7,548 beneficiaries.
How many Baloxavir Marboxil products are on the market?
The Baloxavir Marboxil drug market contains 2 NDCs from 1 manufacturer — 0 generic and 2 brand products.
What is the price range for Baloxavir Marboxil?
NADAC reference prices for Baloxavir Marboxil range from $161.9388 to $161.9469 per EA — a 0% difference between cheapest and most expensive.
Which manufacturers make Baloxavir Marboxil?
1 manufacturer lists Baloxavir Marboxil in NADAC. Ranked by number of NDCs, the largest are Genentech, Inc. (2).